Synthesis and Modification of Carboxylated Multi Wall Nanotubes with Atenolol
Open Access
- 1 January 2014
- journal article
- Published by Scientific Research Publishing, Inc. in Soft Nanoscience Letters
- Vol. 04 (03), 75-81
- https://doi.org/10.4236/snl.2014.43011
Abstract
In this paper functionalized multiwall carbon nanotubes (FMWCNT) were modified using atenolol as a class of drugs that were used in cardiovascular diseases containing reactable nitrogen, which could attach chemically to functionalized MWCNT. This product was characterized by Fourier transform infrared spectroscopy (FT-IR) and Raman spectroscopy. These spectrums proved the existence of nitrogen atoms of amide due to new functional group. The morphology were also determined by scanning electron microscopy (SEM) and showed that this product was synthesized in the nanometer dimension. Thermal gravimetery (TGA) analysis was also used to evaluate thermal properties.Keywords
This publication has 10 references indexed in Scilit:
- Single Wall Carbon Nanotube Response to Proton RadiationThe Journal of Physical Chemistry C, 2009
- Functionalization of multi-walled carbon nanotubes (MWCNTs) with nitrogen plasma for photovoltaic device applicationCurrent Applied Physics, 2009
- Thermo-physical properties of epoxy nanocomposites reinforced with amino-functionalized multi-walled carbon nanotubesComposites Part A: Applied Science and Manufacturing, 2007
- Applications of carbon nanotubes in drug deliveryCurrent Opinion in Chemical Biology, 2005
- New materials for electrochemical sensing VI: Carbon nanotubesTrAC Trends in Analytical Chemistry, 2005
- Covalent Sidewall Functionalization of Single Wall Carbon NanotubesJournal of the American Chemical Society, 2003
- Chemical functionalization of single walled carbon nanotubesCurrent Applied Physics, 2002
- Reversible sidewall functionalization of buckytubesChemical Physics Letters, 1999
- Solvation of Fluorinated Single-Wall Carbon Nanotubes in Alcohol SolventsThe Journal of Physical Chemistry B, 1999
- Permeability of the blood-brain barrier for atenolol studied by positron emission tomographyJournal of Pharmacy and Pharmacology, 1991